Oct 31, 2018
Neutralizing RNS May Improve Immunotherapy Outcomes
Posted by Nicola Bagalà in category: biotech/medical
Neutralising reactive nitrogen species to make immunotherapy more effective.
Researchers at the University of Notre Dame discovered that amino acid nitration can inhibit the activation of T cells employed in immunotherapy against cancer and that suppression of reactive nitrogen species (RNS) responsible for nitration can significantly boost the effectiveness of immunotherapy [1].
Abstract
Continue reading “Neutralizing RNS May Improve Immunotherapy Outcomes” »